Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Zoledronic Acid in High Risk Giant Cell Tumor of Bone
NCT00889590Phase 2Terminated
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2008
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of zoledronic acid in Giant Cell Tumor of Bone (GCTB), sponsored by Leiden University Medical Center. Started Dec 2008; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
Giant Cell Tumor of Bone (GCTB)
Beyond the preview
Go deeper on NCT00889590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00889590.